South Korean (KOSPI) Biotech Industry Analysis
UpdatedNov 29, 2023
DataAggregated Company Financials
Companies111
- 7D-0.4%
- 3M-0.3%
- 1Y-6.1%
- YTD-1.5%
Over the last 7 days, the Biotech industry has remained flat, although notably ALTEOGEN gained 10%. Unfortunately though, the industry is down 6.1% over the past 12 months. Looking forward, earnings are forecast to grow by 17% annually.
Industry Valuation and Performance
Has the South Korean Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 29 Nov 2023 | ₩59.0t | ₩10.1t | -₩315,765,649,899.00 | 26.1x | -186.7x | 5.8x |
| Fri, 27 Oct 2023 | ₩52.2t | ₩10.2t | -₩239,053,318,689.00 | 27.8x | -218.4x | 5.1x |
| Sun, 24 Sep 2023 | ₩55.7t | ₩10.2t | -₩239,053,318,689.00 | 28.8x | -233.1x | 5.5x |
| Tue, 22 Aug 2023 | ₩57.5t | ₩10.2t | -₩213,622,992,279.00 | 36.8x | -269.1x | 5.6x |
| Thu, 20 Jul 2023 | ₩56.4t | ₩10.3t | -₩151,534,704,579.00 | 25.9x | -372.4x | 5.5x |
| Sat, 17 Jun 2023 | ₩60.8t | ₩10.3t | -₩151,534,704,579.00 | 29.8x | -401.1x | 5.9x |
| Mon, 15 May 2023 | ₩61.2t | ₩11.0t | ₩317.8b | 26.5x | 192.5x | 5.6x |
| Wed, 12 Apr 2023 | ₩63.3t | ₩11.0t | ₩318.9b | 24.2x | 198.4x | 5.7x |
| Fri, 10 Mar 2023 | ₩58.8t | ₩11.3t | ₩964.4b | 25.6x | 61x | 5.2x |
| Sun, 05 Feb 2023 | ₩61.6t | ₩11.3t | ₩970.8b | 25x | 63.5x | 5.4x |
| Tue, 03 Jan 2023 | ₩58.1t | ₩11.4t | ₩685.0b | 23.2x | 84.8x | 5.1x |
| Thu, 01 Dec 2022 | ₩60.4t | ₩10.8t | ₩189.9b | 23.8x | 317.9x | 5.6x |
| Sat, 29 Oct 2022 | ₩59.7t | ₩10.8t | ₩348.0b | 19.1x | 171.4x | 5.5x |
| Mon, 26 Sep 2022 | ₩57.4t | ₩10.8t | ₩391.5b | 20.9x | 146.7x | 5.3x |
| Wed, 24 Aug 2022 | ₩68.6t | ₩10.8t | ₩617.8b | 23.3x | 111x | 6.3x |
| Fri, 22 Jul 2022 | ₩70.5t | ₩10.7t | ₩597.6b | 26.6x | 117.9x | 6.6x |
| Sun, 19 Jun 2022 | ₩61.4t | ₩10.6t | ₩627.1b | 23.4x | 97.9x | 5.8x |
| Tue, 17 May 2022 | ₩63.7t | ₩10.0t | ₩871.1b | 25.8x | 73.1x | 6.4x |
| Thu, 14 Apr 2022 | ₩72.0t | ₩10.0t | ₩898.1b | 27.6x | 80.1x | 7.2x |
| Sat, 12 Mar 2022 | ₩75.1t | ₩9.4t | ₩746.5b | 34.8x | 100.7x | 8x |
| Mon, 07 Feb 2022 | ₩75.6t | ₩9.4t | ₩787.4b | 33.5x | 96x | 8.1x |
| Wed, 05 Jan 2022 | ₩91.3t | ₩9.4t | ₩787.4b | 39.1x | 116x | 9.7x |
| Fri, 03 Dec 2021 | ₩94.0t | ₩9.4t | ₩790.0b | 41.4x | 119x | 10x |
| Sun, 31 Oct 2021 | ₩94.4t | ₩9.2t | ₩988.3b | 38.5x | 95.5x | 10.2x |
| Tue, 28 Sep 2021 | ₩115.3t | ₩9.2t | ₩986.1b | 43.2x | 116.9x | 12.5x |
| Thu, 26 Aug 2021 | ₩118.8t | ₩9.3t | ₩909.7b | 50.7x | 130.6x | 12.8x |
| Fri, 02 Jul 2021 | ₩106.9t | ₩9.3t | ₩909.7b | 53.7x | 117.5x | 11.5x |
| Mon, 05 Apr 2021 | ₩103.5t | ₩9.0t | ₩979.0b | 41.2x | 105.7x | 11.5x |
| Thu, 07 Jan 2021 | ₩107.7t | ₩8.2t | ₩501.3b | 54.1x | 214.9x | 13.1x |
Price to Earnings Ratio
404.2x
Current Industry PE
- Investors are pessimistic on the South Korean Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 8.1x is higher than the industry's current PS ratio of 5.7x.
Past Earnings Growth
- Total earnings for the Biotechnology industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have grown 10% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does South Korean Biotech compare with similar industries?
| KR Market | 0.36% | |
| Healthcare | -0.33% | |
| Biotech | -0.41% | |
| Biotech | -0.41% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A196170 ALTEOGEN | ₩78.60k | 6.9% +₩263.9b | 114.5% | PE629.8x | |
| A215600 SillaJen | ₩6.62k | 51.1% +₩230.3b | -31.6% | PS111.7x | |
| A199800 ToolGen | ₩78.10k | 28.7% +₩137.8b | 49.3% | PS951.7x | |
| A310210 Voronoi | ₩41.80k | 9.7% +₩61.7b | 84.4% | PS1183.9x | |
| A086900 Medy-Tox | ₩223.50k | 4.0% +₩57.2b | 96.2% | PE145.4x |